In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired

Abstract

BACKGROUND - ATP-binding cassette transporter A1 (ABCA1) is a key mediator of cholesterol efflux to apoA-I in cholesterol loaded macrophages, a first step of reverse cholesterol transport (RCT) in vivo. Macrophage specific abca1 inactivation or overexpression, respectively, accelerated or suppressed the development of atherosclerosis in mouse models. However, it is yet to be established that the ABCA1 effect is related to specific changes in RCT from the macrophages in vivo. METHODS AND RESULTS - Bone marrow-derived macrophages from abca1 or abca1 mice were labeled with H-cholesterol-AcLDL or H-cholesterol-LDL and injected into abca1 abca1 or abca1 mice. When injected into abca1 mice, return of H-cholesterol from labeled abca1 macrophages to serum, liver, bile, and feces was reduced by 50% (P=0.01) compared with control. When labeled wild-type macrophages were injected into abca1 mice, as compared with wild-type mice, the return of H-cholesterol to serum, liver, bile, and feces was also reduced. CONCLUSIONS - ABCA1 expression in macrophages contributes significantly to in vivo macrophage RCT. The important residual RCT observed from abca1 macrophages highlight the functionality of transporters that efflux to HDL. © 2007 American Heart Association, Inc.